# How Vetter uses Celonis

**€600,000**: ““We generate about €600,000 in savings annually,” says Dr. Kunze.”

As published on [celonis.com](https://www.celonis.com/solutions/stories/vetter-pharma-process-mining). Captured by usedby on 2026-11-04.

- Company: [Vetter](https://www.usedby.ai/companies/vetter.md)
- Tool: [Celonis](https://www.usedby.ai/tools/celonis.md)
- Industry: [Biotech & Pharma](https://www.usedby.ai/companies/industry/biotech-pharma.md)
- Teams: Process Excellence, Accounts Payable, Deviation Management
- Customer since (as the page says): In 2018 Vetter decided to take their process optimization to the next level with Celonis.

## The use case: how Vetter deploys Celonis

Vetter Pharma uses Celonis process mining to optimize its Accounts Payable process, and to analyze Deviation Management by connecting its Trackwise quality management system. It plans to extend Celonis to more processes such as Accounts Receivable, Order-to-Cash, Purchase-to-Pay and change control.

Summary written by usedby from the source page, in English. The figures are those of Celonis and Vetter, not ours.

> “We generate about €600,000 in savings annually,” says Dr. Kunze. “So that’s a real success story, to generate so much value out of just one process.”

- **99%**: “And that through targeted optimization they brought this number up to a striking 99%.”
- **15%**: “connecting Trackwise® to Celonis had already yielded a 15% reduction in cycle time”
- **6%**: “the first-time-right rate which has already improved by 6%”
- **~6% to ~12%**: “almost doubled the automation rate in AP from ~6% to ~12%.”

> We generate about €600,000 in savings annually from Accounts Payable. So that’s a real success story, to generate so much value out of just one process.
>
> Dr. Samuel Kunze, Head of Process Excellence, Vetter Pharma

Source: [celonis.com](https://www.celonis.com/solutions/stories/vetter-pharma-process-mining), captured 2026-11-04.

## Celonis users in Biotech & Pharma

- [AstraZeneca](https://www.usedby.ai/companies/astrazeneca.md) — Confirmed
- [IQVIA](https://www.usedby.ai/companies/iqvia.md) — Confirmed
- [Novo Nordisk](https://www.usedby.ai/companies/novo-nordisk.md) — Confirmed
- [STADA](https://www.usedby.ai/companies/stada.md) — Confirmed

## What usedby checked

We compared the story with its live page on 2026-11-04.

- Checked: Vetter uses Celonis. Confirmed line. Latest check across sources: 2026-11-04.
- Not checked: the result itself. We quote it; we did not measure it.

---
Source: https://www.usedby.ai/case-studies/vetter-pharma-celonis · How we check: https://www.usedby.ai/methodology
